Waters–Morgan Stanley: investor conference, 201809 supply service Waters presents at Morgan Stanley Global Healthcare Conference

	Period	2018-09-12
	Region	New York, NY
	Country	United States (USA)
	Predecessor	Waters–Morgan Stanley: investor conference, 201709 supply service Waters attends Morgan Stanley Global Healthcare Conference
	Successor	Waters–Morgan Stanley: investor conference, 201909 supply service Waters presents at Morgan Stanley Global Healthcare Conference
	Partner, 1st	Waters Corporation (NYSE: WAT)
	Group	Waters (Group)
	Partner, 2nd	Morgan Stanley (Group)
	Product	Morgan Stanley Global Healthcare Conference 2018 New York
	Product 2	analytical instrument
	Person	O’Connell, Christopher J. (Chris) (Waters 201509– CEO before over 21 years at Medtronic)
	Person 2	Brokmeier, Bryan (Waters 201801 Senior Director Investor Relations)

Thermo Fisher Scientific Inc.. (9/5/18). "Press Release: Waters Corporation Presentation at the Morgan Stanley 16th Annual Global Healthcare Conference to Be Webcast Live". Milford, MA.

Waters Corporation (NYSE:WAT) Chris O'Connell, Chairman and Chief Executive Officer, will speak to the investment community at the Morgan Stanley 16th Annual Global Healthcare Conference to be held at the Grand Hyatt New York, Wednesday, September 12, at 9:55 AM Eastern Time.

Interested investors can access the live webcast of the presentation by logging on to Waters Corporation’s website www.waters.com in the investor relations’ section and clicking on “Morgan Stanley 16th Annual Global Healthcare Conference.”

About Waters

Waters Corporation (NYSE: WAT), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years. With approximately 7,000 employees worldwide, Waters operates directly in 27 countries, including 11 manufacturing facilities, and with products available in more than 100 countries.

Waters Corporation
Bryan Brokmeier, 508-482-3448
Senior Director Investor Relations